Explore a potential trade with CytomX (CTMX) stock as Q1’26 clinical data approaches for its EpCAM-targeting therapy. Read ...

Verzenio is the first contemporary therapy in over two decades to demonstrate a significant overall survival benefit in adjuvant HR+, HER2−, high-risk ...

Detailed price information for Gilead Sciences Inc (GILD-Q) from The Globe and Mail including charting and trades.

Feeling sick at sea? Learn what to do right away, from alerting the ship's doctor to managing your symptoms and preventing an ...

The lack of care at the jail led to the detainee's death, the lawsuit alleges. The woman had been detained for seven days before she died.

For patients with ≥4 positive nodes, or with 1–3 nodes plus high-risk features, abemaciclib is now recommended in addition to ...

What is the ‘golden dose’ and what are the risks? Medical News Today asks four experts to weigh in on the trend of trying to ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...

Since its debut in the US in March 2025, Letybo has been positioned as Botox’s biggest competitor in the injection space. And ...

The threat of a government shutdown looms over Washington this week, as President Donald Trump was set to meet with key congressional leaders at the White House on Monday, Sept. 29, less than 48 hours ...